-60%

est. 2Y upside i

Series A

Seen Health is providing exceptional aging experiences by offering seniors culturally-focused, technology-enabled care built on the proven 50-year legacy of PACE (Program of All-Inclusive Care for the Elderly). The company's mission is to empower older adults to age at home with dignity, comfort, and the care they deserve. Committed to improving access to high-quality, long-term care, Seen Health proudly supports underserved senior communities so they can be truly Seen.

Rank

#469

Sector

Senior Care Technology

Est. Liquidity

~6Y

Data Quality

Data: Medium

Seen Health presents a strong upside opportunity for a job seeker, with an estimated expected upside of approximately 118%.

Last updated: March 10, 2026

Bull (30%)+400%

Seen Health successfully scales its culturally-focused PACE model across multiple new markets, leveraging its proprietary technology platform to achieve superior patient outcomes (e.g., maintaining 77% fewer acute hospital bed days) and operational efficiency. This leads to rapid enrollment growth, attracting a strategic acquisition by a major healthcare player or a successful IPO at a valuation of approximately $356M (5x current valuation).

Base (35%)+75%

Seen Health establishes a strong foothold in its initial California markets, demonstrating consistent growth in PACE enrollment within the Asian and Pacific Islander community. The technology platform proves effective, leading to moderate expansion and a valuation of approximately $125M (1.75x current valuation) through a Series B or C funding round, or a modest acquisition.

Bear (35%)-80%

Seen Health faces significant challenges in scaling its operations due to high regulatory hurdles and intense competition from larger PACE providers like WelbeHealth and InnovAge. Slower-than-expected enrollment growth and continued high capital intensity lead to a down round or an unfavorable acquisition, resulting in a valuation of approximately $14M (0.2x current valuation) and significant loss of common stock value for employees given the preference stack.

Est. time to liquidity~6.0 years

Preference Stack Risk

severe

Investors hold $22M in liquidation preferences. In an exit at or below $22M, common stock would receive little to nothing. At the estimated $71.19M post-money valuation, investors would receive their $22M back, leaving $49.19M for common shareholders.

Dilution Risk

high

As a Series A company, Seen Health will likely require multiple additional funding rounds (Series B, C, etc.) to scale, which will lead to significant future dilution for current equity holders.

Secondary Liquidity

none

Given its early stage (Series A), there is currently no active secondary market or tender offers for Seen Health's equity.

Other — 27 roles

View all 27 open roles at Seen Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Seen Health's data — designed to show you've done your homework.

  • 1

    “Given Seen Health's success in achieving 77% fewer acute hospital bed days, how does the company plan to leverage these quantifiable outcomes to accelerate growth, attract new patient populations, and potentially secure partnerships with larger healthcare systems or payers?”

  • 2

    “The PACE model involves high regulatory barriers. How is Seen Health strategically approaching multi-state expansion, particularly in balancing the need for rapid growth with maintaining its culturally-focused care model and navigating diverse state-specific regulations?”

  • 3

    “Considering the Series A funding round and the company's high capital intensity, what is the anticipated timeline for future funding rounds, and how does Seen Health plan to manage potential dilution for early employees as it scales towards a liquidity event?”

Community

Valuation Sentiment

Our model estimates -60% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.